Efficacy and safety of FTY720 in patients who receive a kidney transplant.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Ciclosporin; Fingolimod; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis; Novartis Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 01 Nov 2011 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 29 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History